This page contains brief information about tremelimumab-actl and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Tremelimumab-actl is approved to treat adults with:
- Hepatocellular carcinoma (a type of liver cancer) that cannot be removed by surgery. It is used with durvalumab.
- Non-small cell lung cancer that has spread to other parts of the body and does not have an abnormal EGFR or ALK gene. It is used with durvalumab and platinum-based chemotherapy.
Tremelimumab-actl is also being studied in the treatment of other types of cancer.
More About Tremelimumab-actl
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Tremelimumab-actl - Check for trials from NCI's list of cancer clinical trials now accepting patients.